Adverse Event Reports Linked To Invokana Use Support Lawsuit Plaintiffs

May 14, 2016 – – TheProductLawyers.com reports over 150 adverse event reports have been transmitted to the U.S. FDA concerning the diabetes drug Invokana and metabolic acidosis, a condition where blood acidity increases to a dangerous level, leading to further serious health problems. ICMP, the Institute for Safe Medication Practices, publishes “QuarterWatch” that analyzes FDA adverse event reports. The publication tallied nearly 5,500 adverse events submitted to the FDA in the last year that listed Invokana use, with 168 linked to potential metabolic acidosis.

The class of drugs of which Invokana is a part, SGLT2 inhibitors, contains several other products that are linked to reports of acidosis, though not to the same degree as Invokana. The U.S. Food and Drug Administration has repeatedly issued bulletins warning about possible life-threatening side effects such as urinary tract infections which can evolve into broader infections. As these infections spread, they can put the kidneys or blood at risk. Invokana’s mechanism of action, as with others in the SGLT2 inhibitor class, lowers a diabetic’s blood glucose by redirecting the sugar to be eliminated in the patient’s urine. A higher concentration of sugar in the urinary tract can increase the probability of developing a urinary tract infection (UTI) which could also lead to other serious infections.

Beyond infection, Invokana carries an increased risk for a potentially fatal condition called diabetic ketoacidosis — DKA. This condition which has been linked to the use of the drug results from a severe shortage of insulin. This is followed by a breakdown of fat instead of glucose in the blood, resulting in the release of toxic, acidifying ketones into the bloodstream. As the ketone level rises, the patient is placed in more danger and requires immediate medical attention. This condition has been known to occur in as little as 24 hours and has in some instances had fatal outcomes.

For more information about the Invokana lawsuits, or this press release, please contact TheProductLawyers.com on 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009934